
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK
Qiming Zhou, Qianlei Zhou, Qinghua Liu, et al.
Theranostics (2020) Vol. 10, Iss. 22, pp. 10345-10359
Open Access | Times Cited: 19
Qiming Zhou, Qianlei Zhou, Qinghua Liu, et al.
Theranostics (2020) Vol. 10, Iss. 22, pp. 10345-10359
Open Access | Times Cited: 19
Showing 19 citing articles:
PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types
Pei Ling Chia, Koon Hwee Ang, Min Thura, et al.
Theranostics (2023) Vol. 13, Iss. 6, pp. 1876-1891
Open Access | Times Cited: 14
Pei Ling Chia, Koon Hwee Ang, Min Thura, et al.
Theranostics (2023) Vol. 13, Iss. 6, pp. 1876-1891
Open Access | Times Cited: 14
Comprehensive molecular characteristics of hepatocellular carcinoma based on multi-omics analysis
Yingying Wang, Wan-Xia Yang, Jianhui Cai, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Yingying Wang, Wan-Xia Yang, Jianhui Cai, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
PRL-3: unveiling a new horizon in cancer therapy
Zhiyong Cao, Jingtao Mao, Chao Huang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Zhiyong Cao, Jingtao Mao, Chao Huang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Integrated analysis of single-cell and bulk RNA-sequencing reveals tumor heterogeneity and a signature based on NK cell marker genes for predicting prognosis in hepatocellular carcinoma
Shuo Li, Hongbo Du, Danan Gan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Shuo Li, Hongbo Du, Danan Gan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Hepatitis B virus X protein and TGF-β: partners in the carcinogenic journey of hepatocellular carcinoma
Wei Yan, Dean Rao, Feimu Fan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Wei Yan, Dean Rao, Feimu Fan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma
Qianlei Zhou, Jianhong Lin, Yongcong Yan, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 12
Qianlei Zhou, Jianhong Lin, Yongcong Yan, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 12
Protein Tyrosine Phosphatase PRL-3: A Key Player in Cancer Signaling
Haidong Liu, Xiao Li, Yin Shi, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 342-342
Open Access | Times Cited: 2
Haidong Liu, Xiao Li, Yin Shi, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 342-342
Open Access | Times Cited: 2
PRL-3 dephosphorylates p38 MAPK to promote cell survival under stress
Yin Shi, Shengfeng Xu, Natalie Ngoi, et al.
Free Radical Biology and Medicine (2021) Vol. 177, pp. 72-87
Open Access | Times Cited: 11
Yin Shi, Shengfeng Xu, Natalie Ngoi, et al.
Free Radical Biology and Medicine (2021) Vol. 177, pp. 72-87
Open Access | Times Cited: 11
Hepatitis B Virus X Protein Represses Expression of Tumor Suppressor PTPN18 in Hepatocellular Carcinoma
Zhenyu Zhou, Wei Yu, Huoming Li, et al.
Molecular Cancer Research (2024) Vol. 22, Iss. 9, pp. 891-901
Closed Access | Times Cited: 1
Zhenyu Zhou, Wei Yu, Huoming Li, et al.
Molecular Cancer Research (2024) Vol. 22, Iss. 9, pp. 891-901
Closed Access | Times Cited: 1
Role of Protein Phosphatases in Tumor Angiogenesis: Assessing PP1, PP2A, PP2B and PTPs Activity
Márton Fonódi, Lilla Nagy, Anita Boratkó
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6868-6868
Open Access | Times Cited: 1
Márton Fonódi, Lilla Nagy, Anita Boratkó
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6868-6868
Open Access | Times Cited: 1
The mechanism of TGF-β mediating BRD4/STAT3 signaling pathway to promote fibroblast proliferation and thus promote keloid progression
Ruiqi Bai, Lixia Hao, Guiwen Zhou, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38188-e38188
Open Access | Times Cited: 1
Ruiqi Bai, Lixia Hao, Guiwen Zhou, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38188-e38188
Open Access | Times Cited: 1
FGF19 Is Coamplified With CCND1 to Promote Proliferation in Lung Squamous Cell Carcinoma and Their Combined Inhibition Shows Improved Efficacy
Yanshuang Zhang, Tingyu Wu, Fan Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Yanshuang Zhang, Tingyu Wu, Fan Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
The TIGD5 gene located in 8q24 and frequently amplified in ovarian cancers is a tumor suppressor
Yuntao Dai, Tetsuya Kawaguchi, Miki Nishio, et al.
Genes to Cells (2022) Vol. 27, Iss. 11, pp. 633-642
Open Access | Times Cited: 3
Yuntao Dai, Tetsuya Kawaguchi, Miki Nishio, et al.
Genes to Cells (2022) Vol. 27, Iss. 11, pp. 633-642
Open Access | Times Cited: 3
Co-amplification of genes in chromosome 8q24: a robust prognostic marker in hepatocellular carcinoma
Yongjian Zheng, Yuan Cheng, Cheng Zhang, et al.
Journal of Gastrointestinal Oncology (2021) Vol. 12, Iss. 3, pp. 1086-1100
Open Access | Times Cited: 3
Yongjian Zheng, Yuan Cheng, Cheng Zhang, et al.
Journal of Gastrointestinal Oncology (2021) Vol. 12, Iss. 3, pp. 1086-1100
Open Access | Times Cited: 3
Characterizing PTP4A3/PRL-3 as the Potential Prognostic Marker Gene for Liver Hepatocellular Carcinoma
Xin Jin, Haida Shi, Zhi Li, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 1
Xin Jin, Haida Shi, Zhi Li, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 1
MiR-21-3p promotes hepatocellular carcinoma progression through regulating Smad7/Yap1.
Yinghui Hong, Mingliang Ye, Dan Wang, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 1
Yinghui Hong, Mingliang Ye, Dan Wang, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 1
MiR-21-3p Promotes Hepatocellular Carcinoma Progression Through Regulating Smad7/Yap1
Yinghui Hong, Dan Wang, Mingliang Ye, et al.
Research Square (Research Square) (2020)
Open Access
Yinghui Hong, Dan Wang, Mingliang Ye, et al.
Research Square (Research Square) (2020)
Open Access
INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma
Qianlei Zhou, Jianhong Lin, Qinghua Liu, et al.
Research Square (Research Square) (2020)
Open Access
Qianlei Zhou, Jianhong Lin, Qinghua Liu, et al.
Research Square (Research Square) (2020)
Open Access
INPP5F Translocates Into Cytoplasm And Interacts With ASPH To Promote Tumor Growth in Hepatocellular Carcinoma
Qianlei Zhou, Jianhong Lin, Yongcong Yan, et al.
Research Square (Research Square) (2021)
Open Access
Qianlei Zhou, Jianhong Lin, Yongcong Yan, et al.
Research Square (Research Square) (2021)
Open Access